Thorough QT/QTc Trial to Evaluate the Effect of the HIV-1 Attachment Inhibitor BMS-626529, Administered as its Prodrug, BMS-663068, on QTc Intervals

Conference Reports for NATAP

15th International Workshop on
Clinical Pharmacology
of HIV and Hepatitis Therapy
May 19- 21, 2014, Washington, DC


Thorough QT/QTc Trial to Evaluate the Effect of the HIV-1 Attachment Inhibitor BMS-626529, Administered as its Prodrug, BMS-663068, on QTc Intervals

	Reported by Jules Levin 15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 19-21 May 2014, Washington DC, USA Hruska MW, Savant IA, Anderson JA, Shah V, Chang I, Adamczyk R, Furlong M, Hanna GJ, Bertz R, Zhu L Bristol-Myers Squibb, Princeton, NJ, USA